pta20201005043
Managers' transactions announcement according to article 19 MAR
Managers' transactions announcement according to article 19 MAR
4basebio AG: Managers' transactions announcement according to article 19 MAR
Heidlelberg (pta043/05.10.2020/16:15 UTC+2) - Announcement
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |
|---|---|---|
| a) | Name | Dr Heikki Lanckriet |
| 2 | Reason for the notification | |
| a) | Position/status | Member of the managing body |
| b) | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | 4basebio AG |
| b) | LEI | 391200H5BDEVHMOV3U10 |
| 4 | Details of the transaction(s) | |
| a) | Description of the financial instrument, type of instrument | Share |
| Identification code | DE000A2YN801 | |
| b) | Nature of the transaction | Sale |
| c) | Price(s) | Volume(s) |
| 2.00 EUR | 554,876.00 EUR | |
| d) | Aggregated price | Aggregated volume |
| 2.00 EUR | 554,876.00 EUR | |
| e) | Date of the transaction | 30.09.2020 UTC+2 |
| f) | Place of the transaction | Outside a trading venue |
| 5 | Explanation | |
| Sale as part of the takeover bid by Sparta AG. | ||
(end)
| Emitter: |
4basebio AG Waldhofer Str. 102 69123 Heidelberg Germany |
|
|---|---|---|
| Contact Person: | Robert Mayer | |
| Phone: | +49 171 3876540 | |
| E-Mail: | robert.mayer@4basebio.com | |
| Website: | investors.4basebio.com | |
| ISIN(s): | DE000A2YN801 (Share) | |
| Stock Exchange(s): | Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate |